Updated: May 19, 2026

Andy Sassine

ICAD INCSEC CIK: 0001515322
Estimated Net Worth
$2.39 Million0.0%vs Last Year
Last Updated: May 19, 2026 11:39 PM EST

Transaction Summary

Total Transactions79
Buy-Sell Ratio0.70
Buy Transactions7
Sell Transactions10

Transaction Volume

Total Volume-$2.43M
Net Volume$3.96M
Buy Volume$762.67K
Sell Volume-$3.20M

Trade Analysis

AVG Trade Size-$7.01K
Largest Trade$874.55K
Most Active MonthAug
Most Active Year2020

Trading Sentiment

OverallBullish
Recent TradeBuying
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Andy Sassine has an estimated net worth of $2.39 Million. This is based on reported shares across multiple companies, which include Gemphire Therapeutics Inc., ACORN ENERGY, INC., EXICURE, INC., ICAD INC, MYnd Analytics, Inc., Arcturus Therapeutics Holdings Inc., and Arcturus Therapeutics Ltd..



2020 was Andy Sassine's most active year for acquiring shares with 11 total transactions. Andy Sassine's most active month to acquire stocks was the month of November. 2025 was Andy Sassine's most active year for disposing of shares, totalling 19 transactions. Andy Sassine's most active month to dispose stocks was the month of June. 2013 saw Andy Sassine paying a total of $874,550.00 for 3,773,200 shares, this is the most they've acquired in one year. In 2024 Andy Sassine cashed out on 50,000 shares for a total of $1,601,500.00, their largest year based on trade value.

Holdings & Transactions

icad inc
Updated: Jul 17, 2025
Form TypeSEC Filing
-1.001.55MJul 17View
30.00K30.00KJan 03View
27.59K27.59KAug 15View
25.26K25.26KApr 01View
30.27K30.27KJan 12View
30.00K30.00KJan 03View
34.71K34.71KOct 30View
12.95K12.95KAug 04View
28.77K28.77KApr 19View
22.06KJun 29 - 07View
30.00K30.00KJan 03View
-0.0220.00K$5.38-$107.50K1.20MScheduledFeb 07 - 08View
-0.0220.00K$6.14-$122.70K1.22MScheduledJan 06 - 07View
30.00K30.00KJan 01View
-0.0220.00K$7.00-$139.90K1.24MScheduledDec 06 - 07View
-0.0220.00K$10.60-$211.90K1.26MScheduledNov 08 - 09View
-0.0220.00K$10.49-$209.80K1.28MScheduledOct 06 - 07View
-0.0220.00K$10.89-$217.70K1.30MScheduledSep 13 - 14View
0.0333.50K1.35MFeb 15View
2.67K2.67KDec 31View
4.00K4.00KSep 30View
-0.0120.00K$9.44-$188.72K1.31MScheduledSep 08 - 09View
-0.0120.00K$10.30-$205.90K1.33MScheduledAug 06 - 07View
-0.0120.00K$9.50-$190.05K1.35MScheduledJul 13 - 14View
3.54K3.54KJun 30View
5.45K5.45KApr 01View
-0.0337.98K$7.51$15.13K1.37MMar 20View
-0.20336.69K$4.26$440.01K1.37MFeb 21View
35.58K35.58KDec 31 - 01View
5.46K5.46KSep 30View
5.51K5.51KJun 28View
6.58K6.58KMar 29View
29.32K29.32KDec 31 - 01View
100.00K$4.00$400.00K100.00KDec 21View
6.52K6.52KSep 28View
6.22K6.22KJun 29View
0.002.84K$3.08$8.75K1.27MMar 30View
0.004.00K1.27MFeb 14View
0.002.54K$3.44$8.75K1.26MDec 29View
0.001.98K$4.42$8.75K1.26MSep 29View
0.002.09K$4.19$8.75K1.26MJun 30View
0.001.82K$4.81$8.75K1.26MMar 31View
0.016.70K$3.24$21.71K1.25MDec 30 - 03View
0.004.00K$5.16$20.64K1.25MJan 04View
0.005.52K$4.01$22.15K1.25MDec 07View
1.24MView
ARCTarcturus therapeutics holdings inc.
Chief Financial Officer Director
Updated: Aug 20, 2025VIEW QUOTE
Form TypeSEC Filing
0.011.24K$16.56$20.50K221.76KAug 15View
-0.011.24K$16.56-$20.50K221.76KAug 15View
60.00K60.00KDec 16View
-0.1850.00K$32.03-$1.60M220.53KJun 12View
75.00K75.00KDec 15View
0.001.22K$17.37$21.25K270.53KAug 15View
125.00K125.00KDec 09View
0.001.07K$18.42$19.67K269.30KAug 15View
85.00K85.00KJun 21View
100.00K368.24KDec 18View
0.025.00K$29.74$148.70K273.25KJun 10View
80.00K80.00KFeb 18View
0.025.65K$9.73$54.96K268.25KDec 05View
0.0410.00K$10.00$100.00K257.60KDec 03View
0.0410.00K$10.90$109.00K247.60KAug 23View
XCURexicure, inc.
Updated: Jun 04, 2021VIEW QUOTE
Form TypeSEC Filing
50.00K50.00KJun 02View
100.00K100.00KMar 05View
200.00KView
NRBOgemphire therapeutics inc.
Updated: Jul 26, 2019VIEW QUOTE
Form TypeSEC Filing
0.1115.00K151.26KJul 24View
10.80K10.80KJan 29View
0.3236.96K$9.47$350.00K152.10KMar 10View
0.088.21K$6.71115.15KAug 10View
60.00K60.00KAug 04View
View
arcturus therapeutics ltd.
Chief Financial Officer Director
Updated: Jan 02, 2019
Form TypeSEC Filing
237.60KView
EMMAmynd analytics, inc.
Updated: Nov 02, 2016VIEW QUOTE
Form TypeSEC Filing
20.00K20.00KNov 01View
0.06250.00K4.30MApr 05View
250.00K250.00KAug 20View
$0.25$874.55K4.05MAug 12View
250.00K250.00KMay 23View
View
ACFNacorn energy, inc.
Updated: Sep 23, 2013VIEW QUOTE
Form TypeSEC Filing
25.00K25.00KSep 20View
301.11KView